Global Anti-Diabetic Drugs Market Research Report 2023

Report ID: 1989632 | Published Date: Jan 2026 | No. of Page: 88 | Base Year: 2025 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Anti-Diabetic Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Biguanides
        1.2.3 Sulfonylureas
        1.2.4 Meglitinides
        1.2.5 Thiazolidinediones
        1.2.6 Dipeptidyl Peptidase IV Inhibitors
        1.2.7 α-Glucosidase Inhibitors
    1.3 Market by Application
        1.3.1 Global Anti-Diabetic Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Type I Diabetes
        1.3.3 Type II Diabetes
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Anti-Diabetic Drugs Market Perspective (2017-2028)
    2.2 Anti-Diabetic Drugs Growth Trends by Region
        2.2.1 Anti-Diabetic Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Anti-Diabetic Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Anti-Diabetic Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Anti-Diabetic Drugs Market Dynamics
        2.3.1 Anti-Diabetic Drugs Industry Trends
        2.3.2 Anti-Diabetic Drugs Market Drivers
        2.3.3 Anti-Diabetic Drugs Market Challenges
        2.3.4 Anti-Diabetic Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Anti-Diabetic Drugs Players by Revenue
        3.1.1 Global Top Anti-Diabetic Drugs Players by Revenue (2017-2022)
        3.1.2 Global Anti-Diabetic Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Anti-Diabetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Anti-Diabetic Drugs Revenue
    3.4 Global Anti-Diabetic Drugs Market Concentration Ratio
        3.4.1 Global Anti-Diabetic Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Anti-Diabetic Drugs Revenue in 2021
    3.5 Anti-Diabetic Drugs Key Players Head office and Area Served
    3.6 Key Players Anti-Diabetic Drugs Product Solution and Service
    3.7 Date of Enter into Anti-Diabetic Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Diabetic Drugs Breakdown Data by Type
    4.1 Global Anti-Diabetic Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Anti-Diabetic Drugs Forecasted Market Size by Type (2023-2028)
5 Anti-Diabetic Drugs Breakdown Data by Application
    5.1 Global Anti-Diabetic Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Anti-Diabetic Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Anti-Diabetic Drugs Market Size (2017-2028)
    6.2 North America Anti-Diabetic Drugs Market Size by Country (2017-2022)
    6.3 North America Anti-Diabetic Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Anti-Diabetic Drugs Market Size (2017-2028)
    7.2 Europe Anti-Diabetic Drugs Market Size by Country (2017-2022)
    7.3 Europe Anti-Diabetic Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Anti-Diabetic Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Anti-Diabetic Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Anti-Diabetic Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Anti-Diabetic Drugs Market Size (2017-2028)
    9.2 Latin America Anti-Diabetic Drugs Market Size by Country (2017-2022)
    9.3 Latin America Anti-Diabetic Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Anti-Diabetic Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Astra Zeneca
        11.1.1 Astra Zeneca Company Detail
        11.1.2 Astra Zeneca Business Overview
        11.1.3 Astra Zeneca Anti-Diabetic Drugs Introduction
        11.1.4 Astra Zeneca Revenue in Anti-Diabetic Drugs Business (2017-2022)
        11.1.5 Astra Zeneca Recent Development
    11.2 Boehringer Ingelheim
        11.2.1 Boehringer Ingelheim Company Detail
        11.2.2 Boehringer Ingelheim Business Overview
        11.2.3 Boehringer Ingelheim Anti-Diabetic Drugs Introduction
        11.2.4 Boehringer Ingelheim Revenue in Anti-Diabetic Drugs Business (2017-2022)
        11.2.5 Boehringer Ingelheim Recent Development
    11.3 Eli Lilly
        11.3.1 Eli Lilly Company Detail
        11.3.2 Eli Lilly Business Overview
        11.3.3 Eli Lilly Anti-Diabetic Drugs Introduction
        11.3.4 Eli Lilly Revenue in Anti-Diabetic Drugs Business (2017-2022)
        11.3.5 Eli Lilly Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Detail
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Anti-Diabetic Drugs Introduction
        11.4.4 Johnson & Johnson Revenue in Anti-Diabetic Drugs Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Anti-Diabetic Drugs Introduction
        11.5.4 Merck Revenue in Anti-Diabetic Drugs Business (2017-2022)
        11.5.5 Merck Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Detail
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Anti-Diabetic Drugs Introduction
        11.6.4 Novartis Revenue in Anti-Diabetic Drugs Business (2017-2022)
        11.6.5 Novartis Recent Development
    11.7 Novo Nordisk
        11.7.1 Novo Nordisk Company Detail
        11.7.2 Novo Nordisk Business Overview
        11.7.3 Novo Nordisk Anti-Diabetic Drugs Introduction
        11.7.4 Novo Nordisk Revenue in Anti-Diabetic Drugs Business (2017-2022)
        11.7.5 Novo Nordisk Recent Development
    11.8 Sanofi
        11.8.1 Sanofi Company Detail
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Anti-Diabetic Drugs Introduction
        11.8.4 Sanofi Revenue in Anti-Diabetic Drugs Business (2017-2022)
        11.8.5 Sanofi Recent Development
    11.9 Teva Pharmaceutical Industries
        11.9.1 Teva Pharmaceutical Industries Company Detail
        11.9.2 Teva Pharmaceutical Industries Business Overview
        11.9.3 Teva Pharmaceutical Industries Anti-Diabetic Drugs Introduction
        11.9.4 Teva Pharmaceutical Industries Revenue in Anti-Diabetic Drugs Business (2017-2022)
        11.9.5 Teva Pharmaceutical Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Anti-Diabetic Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Biguanides
    Table 3. Key Players of Sulfonylureas
    Table 4. Key Players of Meglitinides
    Table 5. Key Players of Thiazolidinediones
    Table 6. Key Players of Dipeptidyl Peptidase IV Inhibitors
    Table 7. Key Players of α-Glucosidase Inhibitors
    Table 8. Global Anti-Diabetic Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Anti-Diabetic Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Anti-Diabetic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Anti-Diabetic Drugs Market Share by Region (2017-2022)
    Table 12. Global Anti-Diabetic Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Anti-Diabetic Drugs Market Share by Region (2023-2028)
    Table 14. Anti-Diabetic Drugs Market Trends
    Table 15. Anti-Diabetic Drugs Market Drivers
    Table 16. Anti-Diabetic Drugs Market Challenges
    Table 17. Anti-Diabetic Drugs Market Restraints
    Table 18. Global Anti-Diabetic Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Anti-Diabetic Drugs Market Share by Players (2017-2022)
    Table 20. Global Top Anti-Diabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Diabetic Drugs as of 2021)
    Table 21. Ranking of Global Top Anti-Diabetic Drugs Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Anti-Diabetic Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Anti-Diabetic Drugs Product Solution and Service
    Table 25. Date of Enter into Anti-Diabetic Drugs Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Anti-Diabetic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Anti-Diabetic Drugs Revenue Market Share by Type (2017-2022)
    Table 29. Global Anti-Diabetic Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Anti-Diabetic Drugs Revenue Market Share by Type (2023-2028)
    Table 31. Global Anti-Diabetic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Anti-Diabetic Drugs Revenue Market Share by Application (2017-2022)
    Table 33. Global Anti-Diabetic Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Anti-Diabetic Drugs Revenue Market Share by Application (2023-2028)
    Table 35. North America Anti-Diabetic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Anti-Diabetic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Anti-Diabetic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Anti-Diabetic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Anti-Diabetic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Anti-Diabetic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Astra Zeneca Company Detail
    Table 46. Astra Zeneca Business Overview
    Table 47. Astra Zeneca Anti-Diabetic Drugs Product
    Table 48. Astra Zeneca Revenue in Anti-Diabetic Drugs Business (2017-2022) & (US$ Million)
    Table 49. Astra Zeneca Recent Development
    Table 50. Boehringer Ingelheim Company Detail
    Table 51. Boehringer Ingelheim Business Overview
    Table 52. Boehringer Ingelheim Anti-Diabetic Drugs Product
    Table 53. Boehringer Ingelheim Revenue in Anti-Diabetic Drugs Business (2017-2022) & (US$ Million)
    Table 54. Boehringer Ingelheim Recent Development
    Table 55. Eli Lilly Company Detail
    Table 56. Eli Lilly Business Overview
    Table 57. Eli Lilly Anti-Diabetic Drugs Product
    Table 58. Eli Lilly Revenue in Anti-Diabetic Drugs Business (2017-2022) & (US$ Million)
    Table 59. Eli Lilly Recent Development
    Table 60. Johnson & Johnson Company Detail
    Table 61. Johnson & Johnson Business Overview
    Table 62. Johnson & Johnson Anti-Diabetic Drugs Product
    Table 63. Johnson & Johnson Revenue in Anti-Diabetic Drugs Business (2017-2022) & (US$ Million)
    Table 64. Johnson & Johnson Recent Development
    Table 65. Merck Company Detail
    Table 66. Merck Business Overview
    Table 67. Merck Anti-Diabetic Drugs Product
    Table 68. Merck Revenue in Anti-Diabetic Drugs Business (2017-2022) & (US$ Million)
    Table 69. Merck Recent Development
    Table 70. Novartis Company Detail
    Table 71. Novartis Business Overview
    Table 72. Novartis Anti-Diabetic Drugs Product
    Table 73. Novartis Revenue in Anti-Diabetic Drugs Business (2017-2022) & (US$ Million)
    Table 74. Novartis Recent Development
    Table 75. Novo Nordisk Company Detail
    Table 76. Novo Nordisk Business Overview
    Table 77. Novo Nordisk Anti-Diabetic Drugs Product
    Table 78. Novo Nordisk Revenue in Anti-Diabetic Drugs Business (2017-2022) & (US$ Million)
    Table 79. Novo Nordisk Recent Development
    Table 80. Sanofi Company Detail
    Table 81. Sanofi Business Overview
    Table 82. Sanofi Anti-Diabetic Drugs Product
    Table 83. Sanofi Revenue in Anti-Diabetic Drugs Business (2017-2022) & (US$ Million)
    Table 84. Sanofi Recent Development
    Table 85. Teva Pharmaceutical Industries Company Detail
    Table 86. Teva Pharmaceutical Industries Business Overview
    Table 87. Teva Pharmaceutical Industries Anti-Diabetic Drugs Product
    Table 88. Teva Pharmaceutical Industries Revenue in Anti-Diabetic Drugs Business (2017-2022) & (US$ Million)
    Table 89. Teva Pharmaceutical Industries Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-Diabetic Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Biguanides Features
    Figure 3. Sulfonylureas Features
    Figure 4. Meglitinides Features
    Figure 5. Thiazolidinediones Features
    Figure 6. Dipeptidyl Peptidase IV Inhibitors Features
    Figure 7. α-Glucosidase Inhibitors Features
    Figure 8. Global Anti-Diabetic Drugs Market Share by Application in 2021 & 2028
    Figure 9. Type I Diabetes Case Studies
    Figure 10. Type II Diabetes Case Studies
    Figure 11. Others Case Studies
    Figure 12. Anti-Diabetic Drugs Report Years Considered
    Figure 13. Global Anti-Diabetic Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Anti-Diabetic Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Anti-Diabetic Drugs Market Share by Region: 2021 VS 2028
    Figure 16. Global Anti-Diabetic Drugs Market Share by Players in 2021
    Figure 17. Global Top Anti-Diabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Diabetic Drugs as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Anti-Diabetic Drugs Revenue in 2021
    Figure 19. North America Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Anti-Diabetic Drugs Market Share by Country (2017-2028)
    Figure 21. United States Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Anti-Diabetic Drugs Market Share by Country (2017-2028)
    Figure 25. Germany Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Anti-Diabetic Drugs Market Share by Region (2017-2028)
    Figure 33. China Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Anti-Diabetic Drugs Market Share by Country (2017-2028)
    Figure 41. Mexico Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Anti-Diabetic Drugs Market Share by Country (2017-2028)
    Figure 45. Turkey Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Anti-Diabetic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Astra Zeneca Revenue Growth Rate in Anti-Diabetic Drugs Business (2017-2022)
    Figure 48. Boehringer Ingelheim Revenue Growth Rate in Anti-Diabetic Drugs Business (2017-2022)
    Figure 49. Eli Lilly Revenue Growth Rate in Anti-Diabetic Drugs Business (2017-2022)
    Figure 50. Johnson & Johnson Revenue Growth Rate in Anti-Diabetic Drugs Business (2017-2022)
    Figure 51. Merck Revenue Growth Rate in Anti-Diabetic Drugs Business (2017-2022)
    Figure 52. Novartis Revenue Growth Rate in Anti-Diabetic Drugs Business (2017-2022)
    Figure 53. Novo Nordisk Revenue Growth Rate in Anti-Diabetic Drugs Business (2017-2022)
    Figure 54. Sanofi Revenue Growth Rate in Anti-Diabetic Drugs Business (2017-2022)
    Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Anti-Diabetic Drugs Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Astra Zeneca
Boehringer Ingelheim
Eli Lilly
Johnson & Johnson
Merck
Novartis
Novo Nordisk
Sanofi
Teva Pharmaceutical Industries
Frequently Asked Questions
Anti-Diabetic Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-Diabetic Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-Diabetic Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Asphalt Paver

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More